NaturaGene-Ai: New Integrative Oncology Test for Repurposed Drugs and Supplements
In the world of cancer care, one size rarely fits all. That’s why Datar Cancer Genetics—a leader in precision medicine testing—has introduced a groundbreaking testing solution designed for patients and practitioners who want to explore evidence-based integrative treatment options alongside conventional care.
The new NaturaGene-Ai Panel uses the same data driven approach to match patients with conventional oncology treatments, but shifts the focus to repurposed drugs and supplements that research suggests may help fight cancer.
How NaturaGene-Ai Works
The NaturaGene-Ai report delivers tailored information on 100 repurposed drugs and supplements to help guide integrative treatment decisions and incorporates the following analysis:
- Genetic Analysis of 20,000+ Markers – Provides a comprehensive look at the cancer’s unique genetic profile.
- Chemosensitivity Ranking – Measuring and ranking the tumor-cell-killing potential of 38 repurposed drugs and supplements.
- Pathway Mapping (KEGG) – Identifying over- or under-expressed cancer pathways.
- Supplement Impact List – Highlighting supplements that shown through scientific studies to impact dysregulated cancer pathways.
Treatments Examined in the Panel
The cancer cell death analysis evaluates a wide range of integrative compounds, such as:
- Ivermectin
- Mebendazole
- Multiple species of mistletoe
- Metformin
- Melatonin
- Fenbendazole
- Niclosamide
- EGCG (Epigallocatechin gallate)
- Chloroquine
- Ascorbic Acid (Vitamin C)
View Example NaturaGene-Ai Report
View List of Drugs & Supplements Tested In NaturaGene-Ai
Supplement Insights for Pathway Support
In addition to its chemosensitivity findings, NaturaGene-Ai may identify supplements that could help address improperly functioning cancer pathways. Examples include:
- Berberine
- Selenium
- Graviola
- Shiitake Extract
- Beta-Carotene
An Integrative Testing Option for Every Need
While NaturaGene-Ai provides the most comprehensive integrative guidance, Datar also offers Chemo-Scale—a chemosensitivity test—for those who want results focused solely on the cancer-cell-killing potential of repurposed drugs and supplements.
A complete list of the repurposed drugs and supplements tested through the chemosensitivity process along with an example report can be found here.
About Datar Cancer Genetics
Datar Cancer Genetics is a multinational, CMS- and CAP-licensed oncology laboratory specializing in blood-based cancer testing that spans the entire care continuum—from early diagnosis, to therapy guidance, and remission monitoring. Their mission is to deliver science-driven tools that help patients and providers make informed, individualized treatment decisions.
📩 To learn more or request testing, contact:
Dr. Keshia Tate
📧 DrKeshiaTate@BPCDX.com
📱 480-955-1094 (texts accepted)
